Sae-Fung, A., Vinayavekhin, N., Fadeel, B., & Jitkaew, S. ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells. Nature Portfolio.
Chicago Style (17th ed.) CitationSae-Fung, Apiwit, Nawaporn Vinayavekhin, Bengt Fadeel, and Siriporn Jitkaew. ACSL3 Is an Unfavorable Prognostic Marker in Cholangiocarcinoma Patients and Confers Ferroptosis Resistance in Cholangiocarcinoma Cells. Nature Portfolio.
MLA (9th ed.) CitationSae-Fung, Apiwit, et al. ACSL3 Is an Unfavorable Prognostic Marker in Cholangiocarcinoma Patients and Confers Ferroptosis Resistance in Cholangiocarcinoma Cells. Nature Portfolio.
Warning: These citations may not always be 100% accurate.